The 29th BIO-Europe in Munich was able to boast record figures: around 6,000 participants for the first time, over 30,000 partnering meetings for the first time at what was already the largest European partnering event for biotech and pharma. However, many other figures are currently pointing back to 2019.
Enhance3D Genomics expands leadership team
AppointmentsCambridge-based Enhanc3D Genomics announced the appointment of Hazel Jones as Chief Operating Officer at beginning of November.
Solar Foods raises €8m in Series B financing
Latest NewsFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
Germany boosts protein transition with €38m
Latest NewsThe Budget Committee of the German Bundestag has announced to channel €38m in funding into the sustainable protein transition next year.
Microharvest GmbH launches SCP-Pilot plant in Lissabon
Latest NewsGerman precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
New CEO for Cellaïon
AppointmentsThe biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.
Paving the way to internationalisation
BackgroundDue to the global niche character of pharmaceutical biotechnology, research collaborations and market entries on an international level are essential. Agility and market knowledge are required to maintain an overview in a rapidly evolving environment and to initiate a sustainable internationalisation process.
AMR: Partnership set to improve in vivo antibiotics testing
Latest NewsThe Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing.
VectorY Therapeutics raises €129m in Series A round
Latest NewsDutch VectorY Tx BV has closed one of this yers’s largest Series A financing rounds in Europe at €129m to push its vecorised antibody pipeline in CNS proteinopathies.
ViaNautis Bio Ltd closes US$25m Series A financing
Latest NewsIntracelluar drug delivery specialist ViaNautis Bio Ltd will use US$25 raised in a Series A financing to push applications of its bionic nanoparticle platform polyNaut.
Recordbreaking BIO-Europe in Munich, but: back to 2019
Latest NewsThe 29th BIO-Europe in Munich was able to boast record figures: around 6,000 participants for the first time, over 30,000 partnering meetings for the first time at what was already the largest European partnering event for biotech and pharma. However, many other figures are currently pointing back to 2019.